Redeye is positive to Bredband2’s acquisition of Bredbandsson, adding about 0.
Redeye expects Smart Eye's Q2, due 21 August, to show a 42% y/y sales growth and a mere SEK4m EBITDA...
Redeye leaves its initial take on Physitrack’s Q2 figures, which overall was line with our expectati...
Redeye further comments on Sivers' plans to merge its Photonics business with a US-listed SPAC.
Försäljningstillväxten fortsätter starkt EQL Pharma ökade de återkommande intäkterna med 47,3 procen...
Sales of ~SEK 20m, but with negative margins This afternoon, Bredband2 announced the acquisition of ...
Net sales came in 4% above our forecast, while adjusted EBITDA was 1% below our expectation for Q2.
Earnings miss driven by one-offs, AUM below ABGSCe Adjusting for the Flowbank impairment and the FTX...
Redeye updates its estimates and fair value range following CTEK’s strong Q2 report published last F...
Suominen's Q2 earnings fell slightly short of Vara consensus expectations, which leaves some uncerta...
Q2e on 29 Aug, expect a slow quarter before more transactions in H2 We lower '24e-'25e EBIT by 31% a...
MoveByBike Europe AB (”MoveByBike” eller ”Bolaget”) är ett logistikföretag som erbjuder hållbara ”la...
Acquires UK-based PDAS, adding ~4% to '25e EBITA A market leader in design, installation, and mainte...
Redeye returns with a positive view on the back of Bredband2’s Q2 2024 report which was in line with...
Suominen’s results continued gradual improvement from Q1, while fell short of Vara Research consensu...
Redeye is positively surprised to see CTEK reporting higher sales and profitability than expected.
Alisa Bank’s H1 profitability was in line with our expectations, with PTP at EUR -2.
Raute’s Q2 figures were mostly impressive even if smaller order flow remains one source of uncertain...
Etteplan's Q2 fell short of our estimates due to continued low customer activity.
Redeye comments on Thunderful Group ahead of its Q2 results (due 21 August).
